Medical Technology

Current search: biotech fda

@techcrunch.com 2 years ago

Sirona Medical Acquires Nines AI’s algorithms to rebuild radiology’s IT from the ground up

@techcrunch.com 2 years ago

Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”

@techcrunch.com 2 years ago

‘It’s almost like placing an IV’: Brain monitoring electrode receives FDA 510(k) clearance

@xconomy.com 3 years ago

FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats

@xconomy.com 3 years ago

FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures

@xconomy.com 3 years ago

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

@xconomy.com 3 years ago

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

@xconomy.com 3 years ago

FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products

@xconomy.com 3 years ago

Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill

@xconomy.com 3 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes

@xconomy.com 4 years ago

Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod

@xconomy.com 4 years ago

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

@xconomy.com 4 years ago

Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA

@xconomy.com 4 years ago

Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy

@xconomy.com 4 years ago

Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines

@xconomy.com 4 years ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 4 years ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 4 years ago

FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

@xconomy.com 4 years ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@xconomy.com 4 years ago

Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More

@xconomy.com 4 years ago

Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More

@xconomy.com 4 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@xconomy.com 5 years ago

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

@xconomy.com 5 years ago

Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges

@xconomy.com 5 years ago

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines

@xconomy.com 5 years ago

Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision

@Primary_Immune 5 years ago

The Remarkable Story Behind the Story of the First FDA Approved #Marijuana-Based Drug (For Rare #Epilepsy) | https://www.cincinnati.com/story/news/2018/06/27/cincinnati-test-site-weed-drug-fda-has-just-approved/732043002/ #MedED #ITRTG #BigData #science #technology #genetics #SNRTG #biotech #Dravet #MedicalMarijuana #inspiration #RareDisease #SciComm By @apsaker https://t.co/eNC61FgOhS

@Primary_Immune 5 years ago

The First #Cannabis-Based Drug (For #Epilepsy) Just Gained FDA Approval; The Remarkable Story Behind the Story https://www.cincinnati.com/story/news/2018/06/27/cincinnati-test-site-weed-drug-fda-has-just-approved/732043002/ #ITRTG #BigData #science #technology #genetics #SNRTG #biotech #Dravet #marijuana #MedicalMarijuana #inspiration #RareDisease #SciComm @apsaker https://t.co/QcweE89RhI

@xconomy.com 5 years ago

Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines

@xconomy.com 5 years ago

Histogen Treatment for Female Hair Loss Cleared for Clinical Testing

@extremetech.com 8 years ago

First cancer-killing virus finally approved by FDA